【レポートの概要（一部）】
1. Report Overview
1.1 Gastric Cancer Therapeutics: Market Overview
1.2 Global Gastric Cancer Therapeutics Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Main Questions Answered by This Analytical Study
1.6 Who is This Report For?
1.7 Methods of Research and Analysis
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2. Introduction to Gastric Cancer Treatment
2.1 Stomach Cancer: An Overview
2.2 Treatments for Stomach Cancer
2.3 Defining the Gastric Cancer Therapies Market
3. Leading Stomach Cancer Drugs
3.1 Herceptin (trastuzumab) – Roche: The First Targeted Drug Approved as a Gastric Cancer Treatment
3.1.1 Herceptin: Treatment of HER2+ Cancer
3.1.2 Herceptin: Method of Administration and Side Effects
3.1.3 ToGA: Pivotal Herceptin Study Led to Approvals
3.1.4 ToGA Trial Results
3.1.4.1 Further Possibilities from the ToGA Results
3.1.5 Herceptin Revenue Forecast 2015-2026: Losing Battle with Biosimilar Trastuzumab
3.2 Cyramza (ramucirumab) – Eli Lilly
3.2.1 REGARD and RAINBOW: Pivotal Cyramza Clinical Trials
3.2.2 Cyramza: VEGF Targeting for the Inhibition of Angiogenesis
3.2.3 Cyramza’s Development: Potential as a Combination Treatment
3.2.4 Cyramza Revenue Forecast 2015-2026
3.3 Taxotere (docetaxel) – Sanofi
3.3.1 Taxotere Revenue Forecast 2015-2026
3.4 Xeloda (capecitabine) – Roche
3.4.1 Xeloda Revenue Forecast 2015-2026
3.5 Abraxane (paclitaxel protein-bound particles) – Celgene/ Taiho Pharmaceutical/Otsuka Pharmaceutical
3.5.1 Abraxane Revenue Forecast 2015-2026
3.6 TS-1 (S-1/Teysuno) – Taiho Pharmaceutical/Otsuka Pharmaceutical
3.6.1 TS-1 Revenue Forecast 2015-2026
3.7 Apatinib (YN968D1) – Jiangsu Hengrui Medicine/LSK BioPartners/Bukwang Pharmaceutical Company
3.7.1 Apatinib Revenue Forecast 2015-2026
4. The Gastric Cancer Treatment R&D Pipeline Analysis 2016-2026
4.1 The Importance of R&D in the Gastric Cancer Treatment Industry
4.2 Perjeta (pertuzumab) – Roche – A Novel HER2 Targeting Mechanism
4.3 Opdivo (nivolumab/ONO-4538) – Bristol-Myers Squibb
4.4 Keytruda (pembrolizumab/MK3475) – Merck/MSD
4.5 TAS-118 – Taiho Pharmaceutical/Otsuka Pharmaceuticals
4.6 TAS-102 – Taiho Pharmaceutical/Otsuka Pharmaceuticals/Servier
4.7 NeuVax (nelipepimut-S) – Galena Biopharma/Dr. Reddy’s Laboratories
4.8 Ipatasertib (GDC-0068/RG7440) – Genentech/Roche/Array BioPharma
4.9 Durvalumab (MEDI4736) – AstraZeneca/MedImmune
4.10 Avelumab- (MSB0010718C) – Merck KGaA/Pfizer
4.11 Claudiximab (IMAB362) – Ganymed Pharmaceutical
4.12 Napabucasin (BBI608) – Boston Biomedical
4.13 AZD4547 – AstraZeneca
4.14 Dovitinib (TKI258) – Novartis
4.15 The Future of the Gastric Cancer Treatment Landscape: Other Compounds of Future Interest
5. Global Gastric Cancer World Market 2015 to 2026: Forecasts and SWOT Analysis
5.1 The Global Gastric Cancer Treatment Market Forecast 2015-2026
5.2 World Revenue Forecasts 2015-2026: Changing Market Shares for the Gastric Cancer Treatment Market
5.3 Chemotherapy Segment Forecast, 2015-2026
5.4 Monoclonal Antibodies Segment Forecast, 2015-2026
5.5 Angiogenesis Inhibitors Segment Forecast, 2015-2026
5.6 Drivers and Restraints of the Gastric Cancer Treatment Market 2015 to 2026
5.6.1 Factors Driving Growth in the Gastric Cancer Treatment Market 2015 to 2026
5.6.1.1 A Rise in the At-Risk Population Will Drive Growth
5.6.1.2 Premium-Pricing of Drugs Will Generate Revenue
5.6.1.3 There is High Unmet Need for Novel Treatments to Improve Poor Prognosis
5.6.1.4 Biomarker Development is Critical to Improving Diagnosis and Prognosis of Gastric Cancer
5.6.1.5 Combination Therapies: Lowering Associated Toxicities and Improving the Safety Profile for Treatments
5.6.2 Factors Restraining the Gastric Cancer Treatment Market 2015 to 2026
5.6.2.1 Loss of Patent Protection Will Open the Market to Generic and Biosimilar Erosion
5.6.2.2 Affordability of Treatment Will Restrain Market Growth Because of Healthcare Budgets
5.6.2.3 Patients are Developing Resistance to Treatment
5.7 SWOT Analysis of the Gastric Cancer Treatment Market 2015 to 2026
6. Leading National Markets for the Gastric Cancer Treatment Market 2015-2026
6.1 Regional Breakdown of the World Gastric Cancer Treatment Market
6.2 World Gastric Cancer Treatment Market: Regional Forecasts 2015-2026
6.2.1 How Will Regional Market Shares Change to 2026?
6.3 The US Gastric Cancer Treatment Market 2015 to 2026
6.4 The EU5 Gastric Cancer Treatment Market 2015 to 2026
6.4.1 The Gastric Cancer Treatment Market in Germany to 2026
6.4.2 The Gastric Cancer Treatment Market in Italy to 2026
6.4.3 The Gastric Cancer Treatment Market in Spain to 2026
6.4.4 The Gastric Cancer Treatment Market in France to 2026
6.4.5 The Gastric Cancer Treatment Market in UK to 2026
6.5 The Japanese Gastric Cancer Treatment Market 2015-2026
6.6 The Gastric Cancer Treatment Market in the Emerging Market: BRIC Market Forecast 2015-2026
6.6.1 The Gastric Cancer Treatment Market in China to 2026
6.6.2 The Gastric Cancer Treatment Market in Brazil to 2026
6.6.3 The Gastric Cancer Treatment Market in Russia to 2026
6.6.4 The Gastric Cancer Treatment Market in India to 2026
7. Research Interview
7.1 Interview with Dr Jun Cai, MD, PhD, Senior Research Fellow, Cardiff China Research Collaborative, Cardiff University, Cardiff, Wales, UK
7.1.1 Biomarkers: An Opportunity in Gastric Cancer Treatment
7.1.2 Challenges in Developing Gastric Cancer Treatments
7.1.3 The Benefits of Using Biomarkers
7.1.4 Targeted Treatment: VEGF Inhibitors
8. Conclusions
8.1 The World Gastric Cancer Treatment Market in 2015
8.2 Market Share Distribution Will Differ Over the Forecast Period
8.3 Leading Gastric Cancer Treatment Drug Companies
8.4 National Market Segments: Changes in Market Share Over the Forecast Period
8.5 Concluding Remarks: The Future of the Gastric Cancer Treatment Market
【レポート販売概要】
■ タイトル：胃がん治療薬の世界市場：研究開発、市場動向、予測■ 英文：Gastric Cancer Drugs - R&D, Trends and Market Forecasts 2016-2026
■ 発行日：2016年6月
■ 調査会社：visiongain
■ 商品コード：VGAIN60708
■ 調査対象地域：グローバル
- 世界のヘモフィリア市場：Global Hemophilia Market 2014-2018TechNavio's analysts forecast the Global Hemophilia market to grow at a CAGR of 6.07 percent over the period 2013-2018. One of the key factors contributing to this market growth is the development of new hemophilia therapeutics. The Global Hemophilia market has also been witnessing the increase in technological innovations. However, the high cost of hemophilia therapeutics could pose a challenge t …
- 抗ウイルス薬の世界市場2017-2021About Antiviral DrugsAntiviral drugs are agents used to cure a viral infection by inhibiting the growth of viral pathogens. There are two types of antiviral agents which includes narrow-spectrum antiviral agents and broad-spectrum antiviral agents. Technavio’s analysts forecast the global antiviral drugs market to grow at a CAGR of 9.48% during the period 2017-2021. [Covered in this report] The re …
- 高圧直流送電（HVDC）の世界市場2016-2026Visiongain calculates the global High Voltage Direct Current (HVDC) transmission market to be worth $30.06bn in 2016. This report addresses the development of the HVDC transmission market, placing analyses and data into the following detailed framework: By geography, application, technology, configuration, component, distance and cabling type. It is essential reading for stakeholders in the power …
- Mucopolysaccharidosis I (MPS I) (Hurler Syndrome)：グローバル臨床試験動向（2014年上半期）Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Global Clinical Trials Review, H1, 2014" provides data on the Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) clinical trial scenario. This report provides elemental information and data relating to the clinical t …
- 女性衛生用洗浄液の世界市場2016-2020About Feminine Hygiene Wash Feminine hygiene washes have been significantly gaining traction with increased awareness. The feminine hygiene washes typically contain water with a combination of antiseptic chemicals. It is also known as douching or vaginal irrigation or rinsing of the vagina. The most common usage of feminine hygiene washes is primarily to reduce the odor of post- menstruation and v …
- 世界におけるバイオメトリック（生体認証）システム市場2013-2023（競争環境、戦略的インサイト）Synopsis This report shows the leading Biometric System market segments in various regions across the world. Details of top companies active across the global Biometric System market are provided, together with market size and forecast 2014 - 2024 for the main players across those areas. Summary The report provides a detailed analysis of the competitive landscape of the Biometric System market. It …
- サイトメガロウイルスワクチンのグローバル市場機会分析（MarketVIEW: Cytomegalovirus vaccines）Cytomegalovirus (CMV) is a member of the herpesvirus family and is widely prevalent throughout the population. In the US around 50-80% of adults are infected by 40 years of age (US CDC figures) whereas in other parts of the world, especially developing countries, prevalence is much higher even at younger ages. Usually CMV infections are dormant causing no significant health issues, however, in cer …
- 世界におけるコネクティッド・カーのエコシステム：市場機会、課題、戦略、予測The growing proliferation of embedded in-vehicle connectivity and smartphone integration platforms has made connected cars one of the fastest growing segments of the IoT (Internet of Things) market. Keen to establish recurring post-sale service revenue streams, all major automotive OEMs are investing in connected car programs. Other ecosystem players, such as mobile operators and telematics specia …
- ソフトウェア定義（SDx）の世界市場予測（～2022）：ソフトウェア定義ネットワーク （SDN）、ソフトウェア定義データセンター （SDDC）、ソフトウェア定義ストレージ （SDS）The software-defined anything market is expected to grow at a CAGR of 31.72% between 2016 and 2022, to reach from USD 3.89 Billion in 2015 to USD 28.09 Billion by 2022. Major growth drivers of the market are centralized security control throughout the enterprise, dynamic provisioning of networking resources, reduced operational cost, easy Quality of Service (QoS) implementation, and unified cloud …
- 市場統合シナリオ：Life Science Intermediates Market Consolidation: Who will not survive?- Will the industry consolidate, decentralize, or undergo a bimodal transformation? - How will the current trends affect the major market segments? - Which companies will enter the market and which will not survive? This new report from Venture Planning Group provides technological know-how of leading life science intermediates companies. The report presents: Internally developed and acquired tech …
- ナフタリンの世界市場2019-2023About this market The high demand for naphthalene sulfonates in China will trigger the naphthalene market growth in the forthcoming years. The country accounts for over 63% of the global consumption of naphthalene and naphthalene sulfonates. These specialty chemicals are often added in concrete admixtures to reduce water consumption while improving the durability, workability, and strength of conc …
- 先進繊維系ガスケットの世界市場2019-2023About this market The growth in the global oil and gas and petrochemical refineries is one of the critical reasons that will drive the advanced fiber-based gasket market. The increase in investments in oil and gas and petrochemical refining facilities have a positive impact on the adoption of advanced fiber-based gaskets. This is because these gaskets have high chemical resistivity and can withsta …
- OraSure Technologies, Inc.：市場シェア分析OraSure Technologies, Inc. Market Share Analysis Summary GlobalData’s new report, “OraSure Technologies, Inc. Market Share Analysis” provides in-depth information on OraSure Technologies, Inc.’s market position in the different medical equipment markets it operates in. The report provides OraSure Technologies, Inc. market share information in one key market category – Infectious Immunology. The re …
- Ossur hf.：市場シェア分析Ossur hf. Market Share Analysis Summary GlobalData’s new report, “Ossur hf. Market Share Analysis” provides in-depth information on Ossur hf.’s market position in the different medical equipment markets it operates in. The report provides Ossur hf. market share information in three key market categories – Orthopedic Prosthetics, Orthopedic Braces and Supports and Compression Therapy. The report al …
- ペクチンの世界市場2017-2021About Pectin Pectin was first discovered in 1790 by the French chemist Louis Nicola Vauquelin. He was able to separate from fruit juice, a water-soluble substance that turns liquids into a gel. The name pectin is derived from the Greek word “pektos” that means curdling or congealing. The beneficial properties of pectin were discovered immediately even before its chemical composition was determined …
